Spiriva (Tiotropium Bromide) (Tiotropium Bromide)


Indications and Reactions:

Role Indications Reactions
Concomitant
Chronic Obstructive Pulmonary Disease 73.6%
Myocardial Ischaemia 4.5%
Depression 4.1%
Hypertension 3.0%
Asthma 1.5%
Colorectal Cancer 1.5%
Colorectal Cancer Metastatic 1.5%
Alpha-1 Anti-trypsin Deficiency 1.1%
Chronic Myeloid Leukaemia 1.1%
Emphysema 1.1%
Product Used For Unknown Indication 1.1%
Systemic Lupus Erythematosus 1.1%
Chronic Hepatitis C 0.7%
Fibromyalgia 0.7%
Insomnia 0.7%
Plasma Cell Myeloma 0.7%
Respiratory Failure 0.7%
Anxiety 0.4%
Atrial Fibrillation 0.4%
Bronchiectasis 0.4%
Weight Decreased 16.5%
Nausea 9.9%
Insomnia 6.6%
Diarrhoea 5.8%
Headache 5.8%
Vomiting 5.8%
Back Pain 5.0%
Suicidal Ideation 5.0%
Tremor 5.0%
Condition Aggravated 4.1%
Death 4.1%
Off Label Use 4.1%
Sleep Disorder 4.1%
Abdominal Pain 3.3%
Renal Failure Acute 3.3%
Depression 2.5%
Fatigue 2.5%
Malaise 2.5%
Pyrexia 2.5%
Blood Pressure Increased 1.7%

Drug Data